Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of British Columbia

$17,500.00

Determining the role of interleukin 10 signaling in type 2 diabetes and the impact of exercise on relieving interleukin 10 resistance

FY 2020-21

Summary
Type 2 diabetes (T2D) is a worldwide health problem. It involves chronic low-grade inflammation, caused by dysregulation of small signaling proteins called cytokines. Typically, high expression of pro-inflammatory cytokines and low levels of anti-inflammatory cytokines are seen in T2D. Interleukin (IL)-10 is an anti-inflammatory cytokine, and low levels have been observed in T2D. However, the mechanism behind this remains unclear. Exercise has been shown to increase levels of IL-10, so it should be investigated as a therapeutic strategy. Thus, this research will investigate levels of IL-10 across the health-disease continuum of T2D, as well as how an exercise intervention alters IL-10 function. This will be important for developing therapeutic options for individuals with or at risk for T2D. I hypothesize that there will be a dose-response relationship between glycemia level and IL-10 function across the health-disease continuum, and exercise interventions will improve IL-10 function. To determine whether there is a dose-response relationship between glycemic levels and IL-10 function, I will test levels of IL-10 in the plasma of individuals with normoglycemia, prediabetes and T2D. I will test the anti-inflammatory ability of IL-10 by measuring inhibition of lipopolysaccharide-induced tumour necrosis factor alpha in each of these groups. To elucidate the mechanism of altered anti-inflammatory IL-10 function in T2D, I will examine IL-10 receptor expression on monocytes, and test levels of two transcription factors that regulate IL-10 expression. I will test the impact of exercise on these variables by measuring IL-10 quantity and function in blood samples taken before and immediately after a standard bout of exercise in individuals across the health-disease continuum.
Program
Master's Award: Canada Graduate Scholarships
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
449586
Name
Barber Gemma
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Determining the role of interleukin 10 signaling in type 2 diabetes and the impact of exercise on relieving interleukin 10 resistance
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Elisa; Exercise; Flow Cytometry; Glycemia; Health-Disease Continuum; Inflammation; Interleukin 10; Transcription Factors; Type 2 Diabetes
Abstract
Type 2 diabetes (T2D) is a worldwide health problem. It involves chronic low-grade inflammation, caused by dysregulation of small signaling proteins called cytokines. Typically, high expression of pro-inflammatory cytokines and low levels of anti-inflammatory cytokines are seen in T2D. Interleukin (IL)-10 is an anti-inflammatory cytokine, and low levels have been observed in T2D. However, the mechanism behind this remains unclear. Exercise has been shown to increase levels of IL-10, so it should be investigated as a therapeutic strategy. Thus, this research will investigate levels of IL-10 across the health-disease continuum of T2D, as well as how an exercise intervention alters IL-10 function. This will be important for developing therapeutic options for individuals with or at risk for T2D. I hypothesize that there will be a dose-response relationship between glycemia level and IL-10 function across the health-disease continuum, and exercise interventions will improve IL-10 function. To determine whether there is a dose-response relationship between glycemic levels and IL-10 function, I will test levels of IL-10 in the plasma of individuals with normoglycemia, prediabetes and T2D. I will test the anti-inflammatory ability of IL-10 by measuring inhibition of lipopolysaccharide-induced tumour necrosis factor alpha in each of these groups. To elucidate the mechanism of altered anti-inflammatory IL-10 function in T2D, I will examine IL-10 receptor expression on monocytes, and test levels of two transcription factors that regulate IL-10 expression. I will test the impact of exercise on these variables by measuring IL-10 quantity and function in blood samples taken before and immediately after a standard bout of exercise in individuals across the health-disease continuum.
Competitiondate
202012
Approvedterm2
1 yr 0 mth
Pinamesdelim
Barber, Gemma
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~